Showing results (161-170 of 415) with videos related to
Sort By:
Pageof 42
Arthritis and Rheumatism|November 17, 2001
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesisO Distler, T Pap, O Kowal-Bielecka, et al.Annals of the Rheumatic Diseases|July 26, 2011
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centresJ Fransen, D Popa-Diaconu, R Hesselstrand, et al.Clinical Rheumatology|February 23, 2018
The safety of iloprost in systemic sclerosis in a real-life experienceS Bellando-Randone, C Bruni, G Lepri, et al.Annals of the Rheumatic Diseases|December 8, 2007
Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control studyB Rozman, S Cucnik, S Sodin-Semrl, et al.Clinical and Experimental Rheumatology|August 11, 2004
The expression of cyclooxygenase-1, cyclooxygenase-2 and 5-lipoxygenase in inflammatory muscle tissue of patients with polymyositis and dermatomyositisJ T Studýnková, S Kuchen, E Jeisy, et al.Annals of the Rheumatic Diseases|October 30, 2008
European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature researchJ Avouac, O Kowal-Bielecka, R Landewe, et al.Collagen and Related Research|June 1, 1987
Influence of fibronectin on the fibrillogenesis of type I and type III collagenM L Speranza, G Valentini, A CalligaroEuropean Journal of Biochemistry|August 17, 1990
Fructose-1,6-bisphosphate-activated pyruvate kinase from Escherichia coli. Nature of bonds involved in the allosteric mechanismM L Speranza, G Valentini, M MalcovatiReumatismo|December 29, 2005
[The arthropathy of systemic sclerosis]D Malesci, G La Montagna, G ValentiniRheumatology (Oxford, England)|June 3, 2009
Pulmonary complications: one of the most challenging complications of systemic sclerosisA U Wells, V Steen, G ValentiniPageof 42